Logynon ED

What is it?

A hormonal contraceptive preparation containing oestrogen and progestogen available as sugar-coated tablets. 6 brown tablets contain 30µg of ethinyloestradiol and 50µg of levonorgestrel; 5 white tablets contain 40µg of ethinyloestradiol and 75µg of levonorgestrel; 10 ochre colured tablets contain 30µg of ethinyloestradiol and 125µg of levonorgestrel; 7 white tablets contain inert lactose (a form of sugar).

Medical Uses

Oral contraception.

Dosage

Women, 1 tablet daily in order directed on packet, for 28 days starting on the first day of the cycle. Start new pack straight away.

Special Care

Hypertension, severe kidney disease receiving dialysis, Raynaud's disease, diabetes, multiple sclerosis, asthma, varicose veins, elevated levels of prolactin (a hormone) in the blood (hyperprolactinemia). Risk of thrombosis increases with smoking, age and obesity. Blood pressure, breasts and pelvic organs should be checked during period of treatment.

Avoid Use

Pregnancy, heart and circulatory diseases, angina, sickle cell anaemia, pulmonary hypertension. Also, hormone-dependent cancers, undiagnosed vaginal bleeding, chorea, liver disease, history of cholestatic jaundice of pregnancy, infectious hepatitis, Dublin-Johnson syndrome, Rotor syndrome, recent hvperprolcrctinemiti disease.

Possible Drug and Food Interactions

Phenytoin, carbamazepine, tetracyclines, primidone, chloral hydrate, glutethimide, phenylbutazone, rifampicin, griseofulvin, ampicillin, dichloralphenazone, ethosuximide, barbiturates, St John's Wort.

Known Side Effects

Feeling of bloatedness due to fluid retention, leg pains, breast enlargement, erosion of cervix, muscular cramps, weight gain, breakthrough bleeding, depression, headaches, vaginal discharge, loss of libido, nausea, brown patches on skin (chloasma). Stop drug immediately in event of pregnancy, if frequent, severe headaches occur or signs of thromboses, severe pain in upper abdominal region, enlarged liver, jaundice, rise in blood pressure, severe depression, increased number of fits. Drug should be discontinued 6 weeks before major planned surgery and restarted 2 weeks afterwards, as long as woman is fully mobile. Should be discontinued during long periods of immobility.